{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:53:51Z","timestamp":1774511631666,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ygyno.2004.04.018","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T12:36:14Z","timestamp":1090413374000},"page":"204-207","source":"Crossref","is-referenced-by-count":11,"title":["Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia"],"prefix":"10.1016","volume":"94","author":[{"given":"Lee-may","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst R","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bethan Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2004.04.018_BIB1","first-page":"813","article-title":"Treatment of high-risk choriocarcinoma","volume":"29","author":"Bagshawe","year":"1984","journal-title":"J. Reprod. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2004.04.018_BIB2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","article-title":"The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment","volume":"11","author":"Kohorn","year":"2001","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2004.04.018_BIB3","first-page":"1015","article-title":"Actinomycin D in the treatment of methotrexate resistant trophoblastic disease in women","volume":"22","author":"Ross","year":"1962","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2004.04.018_BIB4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/1097-0142(197509)36:3<863::AID-CNCR2820360306>3.0.CO;2-G","article-title":"Actinomycin D as the primary agent for gestational trophoblastic disease","volume":"36","author":"Osathanondh","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2004.04.018_BIB5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0090-8258(80)90004-9","article-title":"Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration","volume":"9","author":"Petrilli","year":"1980","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2004.04.018_BIB6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0090-8258(83)90093-8","article-title":"Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy","volume":"16","author":"Twiggs","year":"1983","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.04.018_BIB7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-8258(84)90157-4","article-title":"Single-dose actinomycin D in the treatment of postmolar trophoblastic disease","volume":"19","author":"Schlaerth","year":"1984","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2004.04.018_BIB8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/1097-0142(19871101)60:9<2173::AID-CNCR2820600910>3.0.CO;2-3","article-title":"Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the gynecologic oncology group","volume":"60","author":"Petrilli","year":"1987","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2004.04.018_BIB9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.04.018_BIB10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6533","article-title":"Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580400263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580400263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T19:28:49Z","timestamp":1549394929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082580400263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S009082580400263X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2004.04.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}